New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against D Download HRPP SOPs Clinical Trials Find a Researcher Tech ID: 00-05 Summary Scientists at National Jewish Health have developed a new agar medium for the isolation of M. tuberculosis from patients. The medium can also be used for testing susceptibility of M. tuberculosis against various drugs such as pyrazinamide. Potential Applications Isolation of M. tuberculosis from patients specimens Sub-cultivation of M. tuberculosis pure cultures Direct and indirect susceptibility testing Advantages of Invention The medium can be used in regular incubators (without supplemental CO2) The medium can be used at pH 6.0 The medium can be used for a test with pyrazinamide The medium is using animal serum (bovine serum for example) instead of OADC The medium is less expensive to produce Pyrazinamide test can be performed more easily and faster State of Development The medium has been successfully tested to isolate M. tuberculosis and for susceptibility with pyrazinamide Further R&D Required Susceptibility testing against other drugs Publication Heifets L. & Sanchez T. J Clin Microbiol. 2000 Apr; 38(4):1498-501. PMID: 10747133 Patent Status U.S. Patents #6,579,694 and #6,951,733 Inventors Heifets L, PhD and Sanchez T. Licensing Potential Available for Licensing. For Further Information, Contact: Emmanuel Hilaire, PhD Director Technology Transfer Office National Jewish Health 1400 Jackson Street, Room M206b Denver, CO 80206 Voice: 303.398.1262 Fax: 303.270.2352 HilaireE@njhealth.org